[go: up one dir, main page]

NO20056055L - Fluorescein-labelled peptides - Google Patents

Fluorescein-labelled peptides

Info

Publication number
NO20056055L
NO20056055L NO20056055A NO20056055A NO20056055L NO 20056055 L NO20056055 L NO 20056055L NO 20056055 A NO20056055 A NO 20056055A NO 20056055 A NO20056055 A NO 20056055A NO 20056055 L NO20056055 L NO 20056055L
Authority
NO
Norway
Prior art keywords
fluorescein
labeled peptides
angiogenesis
optical imaging
relates
Prior art date
Application number
NO20056055A
Other languages
English (en)
Other versions
NO332926B1 (no
Inventor
Magne Solbakken
Alan Cuthbertson
Bard Indrevoll
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20056055A priority Critical patent/NO332926B1/no
Publication of NO20056055L publication Critical patent/NO20056055L/no
Publication of NO332926B1 publication Critical patent/NO332926B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen gjelder nye, peptidbaserte forbindelser og deres bruk i diagnostisk optisk avbilding. Mer spesifikt er oppfmnelsen relatert til bruk av slike peptidbaserte forbindelser som målvektorer som binder seg til reseptorer assosiert med angiogenese. Forbindelsene er merket med fiuorescein og kan brukes som konfrastmidler ved optisk avbilding i diagnostikk av angiogeneserelaterte sykdommer.
NO20056055A 2003-07-08 2005-12-19 Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse NO332926B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20056055A NO332926B1 (no) 2003-07-08 2005-12-19 Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20033115A NO20033115D0 (no) 2003-07-08 2003-07-08 Peptid-baserte forbindelser
PCT/NO2004/000208 WO2005003166A1 (en) 2003-07-08 2004-07-07 Fluorescein-labelled peptides
NO20056055A NO332926B1 (no) 2003-07-08 2005-12-19 Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
NO20056055L true NO20056055L (no) 2006-02-13
NO332926B1 NO332926B1 (no) 2013-02-04

Family

ID=27800789

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20033115A NO20033115D0 (no) 2003-07-08 2003-07-08 Peptid-baserte forbindelser
NO20056055A NO332926B1 (no) 2003-07-08 2005-12-19 Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20033115A NO20033115D0 (no) 2003-07-08 2003-07-08 Peptid-baserte forbindelser

Country Status (9)

Country Link
US (1) US7608243B2 (no)
EP (1) EP1639004B1 (no)
JP (1) JP4993463B2 (no)
CN (1) CN1820025A (no)
AT (1) ATE500271T1 (no)
DE (1) DE602004031617D1 (no)
ES (1) ES2361670T3 (no)
NO (2) NO20033115D0 (no)
WO (1) WO2005003166A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077145A2 (en) * 2000-04-12 2001-10-18 Amersham Health As Integrin binding peptide derivatives
EP1404371B1 (en) * 2001-07-10 2019-03-13 GE Healthcare UK Limited Peptide-based compounds for targeting intergin receptors
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
NO20035683D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av prostatakreft
NO20035681D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft
CA2568601A1 (en) * 2004-06-16 2005-12-29 Ge Healthcare As Peptide-based compounds
US7897142B2 (en) * 2004-06-16 2011-03-01 Ge Healthcare As Peptide based-compounds
US8182790B2 (en) * 2004-11-22 2012-05-22 Ge Healthcare As Contrast agents
GB0428012D0 (en) 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods
CN101272808B (zh) * 2005-01-06 2012-03-21 通用电气医疗集团股份有限公司 光学成像
ES2554993T3 (es) 2009-09-17 2015-12-28 F. Hoffmann-La Roche Ag Sistema de análisis para el análisis de muestras biológicas, métodos y producto de programa informático
PL238871B1 (pl) * 2018-02-13 2021-10-18 Univ Gdanski Peptydomimetyk oraz jego zastosowanie jako środek fluorescencyjny in vitro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
DE19808591C2 (de) * 1998-02-28 2000-02-03 Univ Leipzig Standardisierter durchflußzytometrischer Vollblutassay
WO2001077145A2 (en) * 2000-04-12 2001-10-18 Amersham Health As Integrin binding peptide derivatives
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
EP1404371B1 (en) * 2001-07-10 2019-03-13 GE Healthcare UK Limited Peptide-based compounds for targeting intergin receptors
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
ES2361670T3 (es) 2011-06-21
US20070183977A1 (en) 2007-08-09
NO332926B1 (no) 2013-02-04
JP4993463B2 (ja) 2012-08-08
EP1639004A1 (en) 2006-03-29
US7608243B2 (en) 2009-10-27
ATE500271T1 (de) 2011-03-15
WO2005003166A1 (en) 2005-01-13
CN1820025A (zh) 2006-08-16
JP2007528846A (ja) 2007-10-18
DE602004031617D1 (de) 2011-04-14
NO20033115D0 (no) 2003-07-08
EP1639004B1 (en) 2011-03-02

Similar Documents

Publication Publication Date Title
SA521422068B1 (ar) عوامل مساعدة لـ glp-1r واستخداماتها
CR11042A (es) Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes
NO20056055L (no) Fluorescein-labelled peptides
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
AR066987A1 (es) Anticuerpo monoclonal contra proteina beta-amiloide
GT201000148A (es) Anticuerpos antimesotelina y usos de los mismos
CY1115316T1 (el) Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων
UA109633C2 (uk) Антитіло людини проти тканинного фактора
DOP2006000099A (es) Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
NO20060230L (no) Nye aminobenzofenonforbindelser
NO20074036L (no) Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer
EA201000207A1 (ru) Новые иммуногенные эпитопы для иммунотерапии
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CL2007002689A1 (es) Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
ATE404225T1 (de) Radiofluorierte peptide
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
WO2008136848A3 (en) Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
GB0718957D0 (en) Optical imaging agents
ATE538135T1 (de) Verbindungen auf peptidbasis
EA201490790A1 (ru) Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1
CY1114075T1 (el) Ενωσεις αλφα κετοαμιδιου ως αναστολεις πρωτεασης κυστεϊνης
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
CL2003002293A1 (es) Compuestos derivados de indazol; su composicion farmaceutica; su uso en el tratamiento de hipertension ocular.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees